L
16.76
-1.93%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in USD, from our data supplier.
Revenue
$6.32bn
FY2016FY2025
Net income
$2.84bn
FY2016FY2025
Free cash flow
$1.12bn
FY2016FY2025
Shareholders' equity
$3.27bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.32bn | $5.79bn | $4.40bn | $4.10bn | $3.21bn | $2.36bn | $3.62bn | $2.16bn | $1.06bn | $343.3m |
| Gross profit | $2.62bn | $2.45bn | $1.86bn | $1.66bn | $1.51bn | $917.2m | $1.44bn | $913.2m | $400.3m | $64.3m |
| Research and development | $451.4m | $397.1m | $555.9m | $856.8m | $911.9m | $909.1m | $1.51bn | $300.8m | $136.6m | $64.7m |
| Operating income | −$32.5m | −$118.9m | −$475.6m | −$1.56bn | −$1.14bn | −$1.81bn | −$2.70bn | −$977.7m | −$708.3m | −$692.6m |
| Net income | $2.84bn | $22.8m | −$340.3m | −$1.58bn | −$1.06bn | −$1.75bn | −$2.60bn | −$911.3m | −$688.3m | −$682.8m |
| Diluted earnings per share | 6.81 | 0.06 | -0.87 | -4.28 | -3.14 | -5.57 | -8.55 | -3.83 | -36.23 | -37.93 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $9.03bn | $5.44bn | $4.56bn | $4.56bn | $4.77bn | $4.68bn | $5.69bn | $3.76bn | $3.02bn | $1.25bn |
| Cash and short-term investments | $1.84bn | $1.98bn | $1.69bn | $1.80bn | $2.25bn | $2.25bn | $2.85bn | $2.04bn | $2.39bn | $1.01bn |
| Total liabilities | $5.76bn | $4.67bn | $4.02bn | $4.17bn | $3.43bn | $3.00bn | $2.84bn | $1.93bn | $5.00bn | $313.9m |
| Debt | $1.13bn | $1.08bn | $951.7m | $874.5m | $739.2m | $707.4m | — | — | — | — |
| Shareholders' equity | $3.27bn | $767.0m | $541.5m | $388.7m | $1.34bn | $1.68bn | $2.85bn | $1.83bn | −$1.98bn | $935.0m |
| Shares outstanding | 418m | 414m | 389m | 370m | 338m | 315m | 305m | 238m | 19m | 18m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | $1.17bn | $849.7m | −$98.2m | −$237.3m | −$101.7m | −$1.38bn | −$105.7m | −$280.7m | −$393.5m | −$487.2m |
| Capital spending | −$52.8m | −$83.5m | −$149.8m | −$115.0m | −$79.2m | −$93.6m | −$178.1m | −$70.9m | −$12.0m | −$8.8m |
| Free cash flow | $1.12bn | $766.3m | −$248.1m | −$352.3m | −$180.9m | −$1.47bn | −$283.8m | −$351.5m | −$405.5m | −$496.0m |
| Dividends paid | — | — | — | −$6.7m | −$7.5m | −$5.8m | — | — | — | — |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.84bn | $1.65bn | $1.59bn | $1.69bn | $1.59bn | $1.45bn | $1.55bn | $1.52bn |
| Gross profit | $917.1m | $786.3m | $620.9m | $758.0m | $652.4m | $587.3m | $675.7m | $634.4m |
| Operating income | $83.9m | $25.0m | −$185.0m | $48.9m | $49.4m | $12.1m | $28.0m | −$56.7m |
| Net income | $50.3m | $14.3m | $2.76bn | $46.1m | $40.3m | $2.6m | $61.7m | −$12.4m |
| Diluted earnings per share | 0.13 | 0.04 | 6.60 | 0.11 | 0.10 | 0.01 | 0.15 | -0.03 |
| Cash from operations | $349.0m | $307.0m | $279.0m | $291.0m | $343.0m | $287.0m | $153.0m | $263.0m |
| Capital spending | −$30.0m | −$20.0m | −$18.0m | −$13.0m | −$14.0m | −$6.0m | −$13.0m | −$21.0m |
| Free cash flow | $319.0m | $287.0m | $261.0m | $278.0m | $329.0m | $281.0m | $140.0m | $242.0m |
| Total assets | $9.11bn | $8.89bn | $9.03bn | $5.94bn | $5.37bn | $5.67bn | $5.44bn | $5.26bn |
| Cash and short-term investments | $1.79bn | $1.72bn | $1.84bn | $1.99bn | $1.79bn | $2.15bn | $1.98bn | $1.93bn |
| Debt | $1.02bn | $1.10bn | $1.12bn | $1.12bn | $626.8m | $1.03bn | $1.02bn | $1.05bn |
| Shareholders' equity | $3.02bn | $3.03bn | $3.27bn | $573.0m | $732.7m | $838.1m | $767.0m | $655.8m |
Financial ratios
Data as of 15 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 41.5% | 42.3% | 42.2% | 40.5% | 46.9% | 38.8% |
| Operating margin | -0.5% | 0.9% | -6.9% | -38.1% | -31.1% | -74.6% |
| Net margin | 45.0% | 0.4% | -7.7% | -38.7% | -33.1% | -74.1% |
| Return on equity | 86.9% | 3.0% | -62.8% | -407.7% | -79.2% | -104.6% |
| Return on assets | 31.5% | 0.4% | -7.5% | -34.8% | -22.2% | -37.5% |
| Free cash flow yield | 17.7% | 13.7% | 0.8% | -2.0% | -0.4% | -24.8% |
| Revenue growth | 9.2% | 31.4% | 7.5% | 27.6% | 35.7% | -34.6% |
| Earnings growth | 12382.5% | -106.7% | -78.5% | 49.2% | -39.4% | -32.6% |
| Current ratio | 0.65x | 0.76x | 0.87x | 0.82x | 1.10x | 1.25x |
| Debt to equity | 0.34x | 1.33x | 1.68x | 2.28x | 0.57x | 0.44x |
| Equity ratio | 36.3% | 14.1% | 11.9% | 8.5% | 28.1% | 35.8% |
| Interest coverage | -1.57x | 1.88x | -11.65x | -78.99x | -19.35x | -54.00x |
| R&D as a share of sales | 7.1% | 6.9% | 12.6% | 20.9% | 28.4% | 38.4% |
| Buybacks as a share of market value | -1.0% | -6.3% | -5.2% | -9.6% | -7.4% | -3.3% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 16.0% | 22.6% | — |
| Operating income | -72.5% | -55.2% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 41.9% | 41.7% | 42.1% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Price to earnings | 2.8 | 234.2 | -17.1 | -1.6 | -8.6 | -5.6 | -3.2 |
| Price to sales | 1.3 | 0.9 | 1.3 | 0.6 | 2.9 | 4.3 | 2.3 |
Market value over time
29 Mar 2019 to 14 Oct 2026, in USD
$1.64bn$6.37bn
Share price return
Finished calendar years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|
| Return | 46% | -10% | 130% | -73% | -23% | 4% | -39% |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.